← Back to Clinical Trials
Recruiting NCT04471740

NCT04471740 Normal Pressure Hydrocephalus and Sleep Apnea

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04471740
Status Recruiting
Phase
Sponsor University of Valencia
Condition Normal Pressure Hydrocephalus
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2020-07-02
Primary Completion 2029-03

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
CSF shunt diversion

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 30 participants in total. It began in 2020-07-02 with a primary completion date of 2029-03.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Normal-pressure hydrocephalus is associated with increases in the intracranial pressure during the night sleep. Sleep apnea also increases the intracranial pressure during the apneic spells. When patients are operated the distal part of the shunt is inserted inside the abdominal cavity, which pressure also increases during the sleep apnea episodes. this is particularly important considering that the recumbent position used to sleep further increases the intraabdominal pressure and that impairs the CSF drainage through the shunt system. The purpose of this study is to analyze the intracranial and intraabdominal pressures during the sleep, particularly during the sleep apnea episodes to see which shunt should be used, to which cavity should be drained (peritoneum or heart) and if correcting the sleep apnea has some positive result on the hydrocephalus symptoms.

Eligibility Criteria

Inclusion Criteria: * Clinical condition compatible with normal-pressure hydrocephalus Exclusion Criteria: * Cerebral vascular disease * Dementia not due to normal-pressure hydrocephalus * Parkinson's disease

Contact & Investigator

Central Contact

Vicente Vanaclocha

✉ vvanaclo@hotmail.com

📞 34669790013

Frequently Asked Questions

Who can join the NCT04471740 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Normal Pressure Hydrocephalus. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04471740 currently recruiting?

Yes, NCT04471740 is actively recruiting participants. Contact the research team at vvanaclo@hotmail.com for enrollment information.

Where is the NCT04471740 trial being conducted?

This trial is being conducted at Valencia, Spain.

Who is sponsoring the NCT04471740 clinical trial?

NCT04471740 is sponsored by University of Valencia. The trial plans to enroll 30 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology